Your browser doesn't support javascript.
loading
Xpert Ultra testing of blood in severe HIV-associated tuberculosis to detect and measure Mycobacterium tuberculosis blood stream infection: a diagnostic and disease biomarker cohort study.
Boloko, Linda; Schutz, Charlotte; Sibiya, Nomfundo; Balfour, Avuyonke; Ward, Amy; Shey, Muki; Nicol, Mark P; Burton, Rosie; Wilkinson, Robert J; Maartens, Gary; Meintjes, Graeme; Barr, David A.
Afiliação
  • Boloko L; Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa; Department of Medicine, University of Cape Town, Cape Town, South Africa. Electronic address: linda.boloko@gmail.com.
  • Schutz C; Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa; Department of Medicine, University of Cape Town, Cape Town, South Africa.
  • Sibiya N; Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
  • Balfour A; Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
  • Ward A; Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa; Department of Medicine, University of Cape Town, Cape Town, South Africa.
  • Shey M; Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa; Department of Medicine, University of Cape Town, Cape Town, South Africa.
  • Nicol MP; Division of Infection and Immunity School of Biomedical Sciences, University of Western Australia, Perth, Australia; Division of Medical Microbiology, National Health Laboratory Services, Groote Schuur Hospital, Cape Town, South Africa.
  • Burton R; Khayelitsha Hospital, Department of Medicine, Cape Town, South Africa.
  • Wilkinson RJ; Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa; Department of Medicine, University of Cape Town, Cape Town, South Africa; The Francis Crick Institute, London, UK; Department of Infec
  • Maartens G; Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.
  • Meintjes G; Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa; Department of Medicine, University of Cape Town, Cape Town, South Africa.
  • Barr DA; Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa; Institute of Infection and Global Health, University of Liverpool, Liverpool, UK.
Lancet Microbe ; 3(7): e521-e532, 2022 07.
Article em En | MEDLINE | ID: mdl-35644157

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose / Tuberculose Pulmonar / Infecções por HIV / Bacteriemia / Sepse / Mycobacterium tuberculosis Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Lancet Microbe Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose / Tuberculose Pulmonar / Infecções por HIV / Bacteriemia / Sepse / Mycobacterium tuberculosis Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Lancet Microbe Ano de publicação: 2022 Tipo de documento: Article